Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q2 2022 Results - Earnings Call Transcript

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q2 2022 Results Earnings Conference Call August 8, 2022 5:00 PM ET

Company Participants

Dan Dischner - Vice President, Corporate Communications
Bill Peters - Chief Financial Officer, Treasurer, Executive Vice President of Finance, and President of International Medication Systems, Ltd.
Tony Marrs - Senior Vice President, Regulatory Affairs

Conference Call Participants

Tim Chiang - Capital One
Elliot Wilbur - Raymond James
Serge Belanger - Needham & Company, LLC
David Amsellem - Piper Jaffray

Operator

Greetings and welcome to the Amphastar Pharmaceuticals Second Quarter Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions].

Please note that certain statements made on this call regarding matters that are not historical facts, including, but not limited to, management's outlook or predictions for future periods are forward-looking statements. These statements are based solely on information that is now available to us. We encourage you to review the section entitled Forward-Looking Statements in the press release issued today and the presentation on the company's website. Also, please refer to our SEC filings, which can be found on our website and the SEC's website, for a discussion of numerous factors that may impact our future performance.

We will also discuss certain non-GAAP measures. Important information on our use of these measures and reconciliations to US GAAP may be found in the earnings release.

Please note that this conference call is being recorded. Our speakers today are Mr. Bill Peters, CFO; Mr. Dan Dischner, VP of Corporate Communications; and Mr.

I will now turn the conference over to your host, Mr. Dan Dischner, Vice President of Corporate Communications. Dan, you may begin.

Dan Dischner

Thank you, Paul. I'd like to thank everyone for joining us for our second quarter earnings call for 2022. We